The Fifth-Generation Cardiac Troponin T and Cardiovascular Disease in the Community

Yasuyuki Honda, Yejin Mok, Junichi Ishigami, Kellan E. Ashley, Ron C. Hoogeveen, Christie M. Ballantyne, Amy B. Karger, David Couper, Elizabeth Selvin, Kunihiro Matsushita

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)2019-2021
Number of pages3
JournalJournal of the American College of Cardiology
Volume78
Issue number20
DOIs
StatePublished - Nov 16 2021

Bibliographical note

Funding Information:
The ARIC study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract nos. HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, HHSN268201700004I. Cardiac troponin T and serum creatinine were measured as an ancillary study (principal investigator, Dr. Matsushita) supported by Kyowa Kirin. Roche Diagnostics provided reagents to measure the 5th generation cardiac troponin T. Dr Hoogeveen has received institutional research funding and consulting fees from Denka Seiken outside the scope of this work. Dr Ballantyne has been a consultant for Roche and Abbott Diagnostics. Dr Karger has been a consultant for Roche Diagnostics; and has received research funding from Siemens Healthcare Diagnostics. Dr Couper has received institutional research funding from Denka Seiken outside the scope of this work. Dr Matsushita has received research funding from Fukuda Denshi; and has received personal fees from Fukuda Denshi and Kyowa Kirin outside of this work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors thank the staff and participants of the ARIC study for their important contributions.

Funding Information:
The ARIC study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract nos. HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, HHSN268201700004I. Cardiac troponin T and serum creatinine were measured as an ancillary study (principal investigator, Dr. Matsushita) supported by Kyowa Kirin. Roche Diagnostics provided reagents to measure the 5th generation cardiac troponin T. Dr Hoogeveen has received institutional research funding and consulting fees from Denka Seiken outside the scope of this work. Dr Ballantyne has been a consultant for Roche and Abbott Diagnostics. Dr Karger has been a consultant for Roche Diagnostics; and has received research funding from Siemens Healthcare Diagnostics. Dr Couper has received institutional research funding from Denka Seiken outside the scope of this work. Dr Matsushita has received research funding from Fukuda Denshi; and has received personal fees from Fukuda Denshi and Kyowa Kirin outside of this work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors thank the staff and participants of the ARIC study for their important contributions.

Cite this